Abstract: Herein we prepare nanohybrids by incorporating iron oxide nanocubes (cubic-IONPs) within a thermo-responsive polymer shell that can act as drug carriers for doxorubicin(doxo). The cubic-shaped nanoparticles employed are at the interface between superparamagnetic and ferromagnetic behavior and have an exceptionally high specific absorption rate (SAR) but their functionalization is extremely challenging compared to bare superparamagnetic iron oxide nanoparticles as they strongly interact with each other. By conducting the polymer grafting reaction using reversible addition-fragmentation chain transfer (RAFT) polymerization in a viscous solvent medium, we have here developed a facile approach to decorate the nanocubes with stimuli-responsive polymers. When the thermo-responsive shell is composed of poly(N-isopropyl acrylamide-co-polyethylene glycolmethylether acrylate), nanohybrids have a phase transition temperature, the lower critical solution temperature (LCST), above 37 °C in physiological conditions. Doxo loaded nanohybrids exhibited a negligible drug release below 37 °C but showed a consistent release of their cargo on demand by exploiting the capability of the nanocubes to generate heat under an alternating magnetic field (AMF). Moreover, the drug free nanocarrier does not 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 2 exhibit cytotoxicity even when administered at high concentration of nanocubes (1g/L of iron) and internalized at high extent (260 pg of iron per cell). We have also implemented the synthesis protocol to decorate the surface of nanocubes with poly(vinylpyridine) polymer and thus prepare pH-responsive shell coated nanocubes.
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Introduction
Emerging technologies in preparation of magnetic nanoparticles have afforded materials with a wide range of potential applications including magnetic resonance imaging (MRI) agents, carriers for drug/gene delivery, hyperthermia agents and biosensors. [1] [2] [3] [4] Non-aqueous synthesis protocols allow for the preparation of iron oxide nanoparticles (IONPs) with control over the crystallinity and thus obtaining particles with desirable magnetic properties for the distinct applications. 5 However, these methods yield hydrophobic nanoparticles capped with organic surfactants which hinder their direct application in biomedicine. 4, 6 With the persistent developments in synthesis of magnetic nanoparticles/IONPs targeted for various biologic applications, there is accordingly the need to continuously develop strategies for their functionalization.
Functionalization of IONPs has been conducted via modification of the IONPs surfaces with small molecules as well as with polymers. 7 The combination of polymers, specifically stimuli-responsive polymers, with inorganic particles represents a fascinating route for generation of new types of materials and devices integrating properties of inorganic particles with those of polymers. 8 The main strategies employed for polymer functionalization of IONPs include the grafting from and grafting to techniques 6, 9 which lately have been employed in combination with living radical polymerization (LRP) techniques. [10] [11] LRP techniques allow rapid access to well-defined functional (co)polymers of varying molecular architecture and thus offer good control over the size of hybrid nanostructures. 12 Herein, we report a potentially generic and facile approach for the functionalization of strongly interacting cubic shaped IONPs (cubic-IONPs) via the grafting from approach using an LRP technique (reversible additionfragmentation chain transfer (RAFT)) polymerization. 13 Although several reports on functionalization of spherical-IONPs (mainly prepared by co-precipitation methods) via RAFT polymerization and other LRP techniques have demonstrated the feasibility to synthesize thermo-responsive shell on top of IONPs, [14] [15] [16] [17] [18] [19] [20] the protocols previously developed have mainly used nanoparticles showing superparamagnetic behavior at room temperature. These nanoparticles are, by their nature, non-interacting particles, as they miss any remanence magnetization at room temperature and in absence of an external magnetic 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   3 field. Very recently, our group has reported the non-hydrolytic synthesis of 19-22 nm cubic-IONPs having a magnetic behavior at the interface between the superparamagnetic and ferromagnetic regime at room/body temperature. In a comparative study, we have observed that cubic-IONPs with sizes of [19] [20] [21] [22] nm have the best heating performance as they show very high specific absorption rates (SAR) values whilst above or below this nanoparticle size range, the SAR values decreases and the heating performance becomes lower. This makes the 19-22 nm cubic-IONPs very promising for hyperthermia applications. 21 Further, they are composed of biocompatible species (only iron and oxygen) and at the same time, they exhibited efficient heat dissipation at frequency and field conditions which are applicable to patients. 22 Given the high SAR values, lower doses of cubic-IONPs could be applied in vivo for reaching therapeutic temperatures. 23 Furthermore, in vivo degradation in liver of those iron oxide nanocubes has been reported by some of us. 24 However, because of their size and magnetic properties those cubic-IONPs strongly interact with each other and many challenges are encountered when trying to functionalize such nanoparticles. 9, 11 Amphiphilic polymer enwrapping and ligand exchange protocols with pegylated molecules have been adapted to allow the nanoparticle water transfer. 22 However, having a functional coating like a thermo-responsive or pH-responsive shell could further enhance their applicability. Herein, using a direct approach, we employ cubic-IONPs as a blueprint of strongly aggregating nanoparticles and we develop protocols at the nanoparticle surface for an in situ polymerization by LRP techniques of responsive polymers: temperature (based on Nisopropylacrylamide, NIPAAM) or pH (based on vinylpyridine,VP). The key to achieve the polymer shell growth on individual cubic-IONPs was the choice of viscous solvents as media in which to perform the polymerization. The thermo-responsive coated cubic-IONPs still preserved their good magnetic properties with the very high SAR values. 22 The temperature responsive cubic-IONPs were used as drug carriers for chemotherapy. Doxorubicin (doxo) molecules were loaded at room temperature and after drug encapsulation released under an alternating magnetic field (AMF) by exploiting the heating ability of the cubic-IONPs. Under an AMF exposure, the temperature of the thermo-responsive cubic-IONPs increased and the accompanying coil-globule transition of the polymer led to expulsion of the drug from the temperature responsive cubic-IONPs. Such nanostructures may then act as drug carriers, providing a synergistic therapeutic effect in cancer treatment via hyperthermia and chemotherapy with triggered drug release, while not displaying side effects presented by standard chemotherapy. 15 In this work, we demonstrate that by conducting the surface functionalization of the cubic-IONPs in a viscous medium we can overcome the challenges associated with the functionalization of such strongly interacting nanoparticles and yield hybrid nanomaterials with a potentially wide range of applications. The parallel 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   4 comparison of the implementation of the same procedures to superparamagnetic spherical-IONPs allows us to highlight the challenges we have encountered when using cubic-IONPs.
Results and discussion

The ligand exchange protocol for the preparation of RAFT functionalized nanocubes
To functionalize the cubic-IONPs with the responsive polymer, we opted for the grafting from approach using RAFT polymerization taking into account the high grafting densities that arise from using this grafting approach and the versatility of the polymerization technique. Following procedures similar to those employed in literature for the functionalization of superparamgnetic IONPs, we first synthesized a catechol bearing RAFT agent (CTCLRA) to act as an anchor for the polymer chains on the surface as the catechol moiety is known to bind strongly to iron oxide surface. 4, 25 The CTCLRA was obtained in good yield (87%) by a two-step reaction between dopamine and succinimide-activated RAFT agent and the structure was confirmed by 1 H NMR (Figure 1 ) (for the characterization of the intermediate compound see Figure S1 of the supporting information, SI). Subsequently, the oleic acid capped cubic-IONPs in CHCl 3 were exchanged with the CTCLRA using a large excess of RAFT agent (the initial mixing ratio was fixed at 16 RAFT agent molecules/nm 2 ) in tetrahydrofuran (THF). It is worth mentioning that we have also observed that the ligand exchange process with the RAFT agent, the CTCLRA, could also be conducted by adding the RAFT agent dissolved in THF directly to the crude reaction mixture obtained at the end of the synthesis procedure of the nanocubes (usually dissolved in squalane/dibenzyl ether). 22 At the end of the synthesis of the cubic-IONPs, the reaction mixture was allowed to cool to 60 o C and without dismantling the apparatus, under argon, the RAFT agent solution in THF was added and the ligand exchange process was left to proceed overnight at room temperature. The CTCLRA-coated nanocubes could be then recovered by centrifugation and be completely resuspended in THF. Also, the CTCLRA exchanged nanocubes were insoluble in hexane which was a good solvent for the starting nanoparticles thus indicating the change in the coating at their surface.
The success of the ligand exchange protocol was probed by FTIR and elemental analysis. After CTCLRA exchange, the amide N-H stretch at 3400 cm -1 in the spectrum of the CTCLRA coated nanoparticles reveal the presence of the RAFT agent at the nanoparticle surface (this peak was absent in the spectrum of the starting nanoparticles) (Figure 1) . Furthermore, the sulfur element which was absent in the as- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   5 synthesized nanocubes (based on ICP) was abundantly detected via elemental analysis only on CTCLRA coated IONPs after ligand exchange, indicating the successful attachment of the sulfur bearing CTCLRA.
Based on the sulfur and iron content measured by ICP, the grafting density was estimated to be 4 molecules/nm 2 .
Figure 1: (A)
1 H NMR spectrum of catechol functionalized RAFT agent (CTCLRA) in DMSO-d 6 and (B)FTIR spectra of CTCLRA and nanocubes before and after ligand exchange with CTCLRA.
Polymerization reaction of thermo-responsive shell on the RAFT-functionalized nanocubes
After functionalizing the cubic-IONPs with CTCLRA, we adopted an approach similar to that employed by Ohno et al. 26 to grow polymer on superparamagnetic nanoparticles for the functionalization of our strongly interacting cubic-IONPs with poly(N-isopropylacrylamide) (PNIPAAM) which is a non-toxic polymer with a lower critical solution temperature (LCST) of about 32 o C in water. 27 Although the transition temperature of PNIPAAM is lower than 37 o C, copolymerizing NIPAAM with hydrophilic/hydrophobic monomers allows tuning of the LCST. However, under the polymerization conditions employed for superparamagnetic nanoparticles and in THF (see the section of the material and methods) the reaction did not give the desired colloidally stable nanohybrids and polymer coated nanocubes precipitated out of solution within the first few minutes of polymerization. Functionalization under continuous stirring on a magnetic stirrer was not possible since the cubic-IONPs are strongly attracted to magnetic surfaces and thus they do not stay dispersed but instead they "rush" to the magnet and clump up at the bottom of the reaction vessel. Functionalization was however possible Figure 2G ). 26 suggesting that in our case, particle aggregation took place under these conditions. This was corroborated by dynamic light scattering (DLS) analysis of the nanocubes which showed multimodal distributions including particles with sizes close to one micron (SI, FigureS2) . Furthermore, the possibility of polymer chain scission during ultrasonication for such long periods also exists. [28] [29] Nevertheless, the use of the ultrasonication bath presented the disadvantage of poor temperature control which led to poor reproducibility of results. To overcome these challenges, we envisioned that, in a "frozen" system, the nanocubes mobility could be reduced and hence their chance to aggregate. As a consequence, the nanocubes would stay longer in solution and polymerization could have higher chance to occur at the surface of individual nanocubes. We thus dispersed the CTCLRA functionalised cubic-IONPs in different solvents having different viscosity (either polyethylene glycol with an average molecular weight of 200 g/mol (PEG200), or PEG400 or diethylene glycol (DEG), or THF, or dimethylformamide (DMF) or 1,4-dioxane). We placed these solutions in a heated water-bath at 60 o C to determine if the nanocubes would remain in solution or they would just precipitate as observed during the polymerization. We observed that the nanocubes in THF, DMF and 1,4-dioxane precipitated out of solution in less than half an hour whilst they remained dispersed after 6 or 24 hours in the more viscous solvents (PEG200, or PEG400 orDEG). Viscous solvents act by impairing the movement of the cubicIONPs and indeed will allow sufficient time for polymer functionalization. Moreover, such solvents have been advocated to be optimal media LRPs. [30] [31] Encouraged by this observation, we first studied the RAFT (co)polymerizations of NIPAAM and Nisopropyl acrylamide mixed with polyethylene glycolmethylether acrylate (NIPAAM/PEGA) in DEG and in 1,4-dioxane, mediated by the succinimide bearing RAFT agent(SUCRA). In this experiment no nanoparticles were present. DEG was found to offer good solubility for the polymerization reagents and also its lower viscosity (compared to PEG400 and PEG200) would ensure delayed plateauing of the molar mass (M n ). The polymerization of NIPAAM in either solvent proceeded in a controlled manner as (Figure 3) . Similarly, the molar masses for the co-polymerizations of NIPAAM and PEGA were observed to increase with time and the obtained polymers also had low PDIs although the M n versus conversion plot could not be obtained due to peak overlap in the NMR spectra. Both the NIPAAM and NIPAAM/PEGA (co)polymerizations were observed to proceed faster in the viscous solvent than those in 1,4-dioxane which is in accordance with the results published by Perrier and co-workers on LRPs in viscous solvents. 30,b Having now set a new solvent of the reaction, we then tried to perform the ligand exchange procedure with CTCLRA in the viscous solvent, by first dispersing the as-synthesized decanoic acid capped cubicIONPs in viscous solvent under ultrasonication prior to adding the CTCLRA in excess (30 molecules/nm 2 ).
Success of the ligand exchange process was confirmed by FTIR as in the previous case and also by TGA ( Figures S3 and S4 of the SI). We however observed no difference in surface coverage obtained using the different methods as by sulfur/iron content by ICP the final coverage ratio was found to be 4 molecules/nm 2 (see experimental section for the formula used). This suggests that the ligand exchange process was not severely impacted on by the strong interaction of the cubic IONPs. This can be explained by taking into account that in both solvent mixtures (THF/CHCl 3 or dioxane or DEG) there is an ultrasonication step which allows the nanocubes to become well dispersed exposing most of their surfaces for ligand exchange to take place and if the exchange process is occurring at similar rates in both cases, the surface coverage will therefore be more or less the same. Moreover, during ultrasonication heat is produced and at higher temperature the nanocubes have low tendency to interact with each other as the magnetic remanence is decreased or cancelled. After a cleaning step, functionalization of CTCLRA-cubic-IONPs (19 nm) with NIPAAM was undertaken in DEG in presence of free SUCRA to control the polymerization (see materials and methods). After removal of free polymer from the reaction mixture, the polymer coated cubic-IONPs were observed to be soluble in water or phosphate buffered saline (PBS) (pH 7.4) at room temperature. As we sought to prepare thermo-responsive IONPs for cancer treatment with thermal response significant for hyperthermia (41-47 o C) , 15, 32 we targeted coil-globule response temperatures above body temperature (37 o C) and maintaining this behavior in physiological conditions (saline buffer solutions at 155 mM of NaCl). Copolymerization of NIPAAM with hydrophilic monomers increases the LCST and thus, we chose to copolymerize NIPAAM with polyethylene glycol methylether acrylate (PEGA). In addition to offering hydrophilicity, polyethylene glycol also has the advantages of being non-toxic (M n > 400 Da but below 40 kDa) as well as reducing in vivo protein adsorption and thus improving biodistribution although few drawbacks PEG dose and PEG molecular weight related should not be neglected (i.e. immunogenic issues due to complement activation and antibody response). 33 Varying in the feed, the initial mole percentage of hydrophilic monomer (PEGA) between 0 and 35% with respect to that of NIPAAM we were able to tune the LCST to a temperature above 37 °C thus ensuring cargo (drug) encapsulation and water solubility at temperatures below this value and conversely cargo release at temperatures recommended for hyperthermia above 40 °C ( Figure 4 ).
Thus, using our functionalization procedure, the LCST of the hybrid cubic-IONPs could be easily modified by copolymerizing NIPAAM with PEGA ( Figure 4A ). Below LCST the nanocubes were completely soluble while above the LCST, the nanocubes collapsed (inset images of figure 4A) and this behavior was totally reversible by switching the temperature. The copolymerization with a monomer feed composition of 80% mol NIPAAM and 20% mol PEGA was studied over time and found to give hybrid nanostructures with an LCST of 45 o C. Analysis of the thermo-responsive cubic-IONPs by TGA revealed an increase in % weight loss with increasing polymerization time which corresponds with gradual molar mass increase observed in LRPs ( Figure 4C ). Analysis of the free polymers by size exclusion chromatography (SEC) indicated that the molar mass increased with time although the PDI values were relatively high (1.5-1.7)
( Figure 4D ). These PDI values were however lower than those obtained when the polymerizations were 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 12 conducted using oleic acid capped cubic-IONPs in the absence of free RAFT agent (2.5-4.3) suggesting the grafting from polymerizations done using CTCLRA coated nanocubes was controlled albeit with less efficiency. Finally, by FTIR, the amide (C=O and N-H) and ester (C=O) peaks indicate the presence of the thermo-responsive polymer shell present at the nanocube surface ( Figure 4B ).
The thermo-responsive cubic-IONPs also exhibited magnetization properties (at low temperature, 5K) similar to those of the as synthesized or PEG water transferred cubic-IONPs reported previously ( Figure   5 ). 22 Noteworthy, at 300 K and high magnetic fields (above 5 kOe) the magnetization signal for the polymer coated nanocubes system decreases while increasing the magnetic field ( Figure 5B ). This is due to the diamagnetic contribution of the polymer which becomes relevant at high temperatures and fields. 34 As a result, and depending on the amount of polymer (and possible solvent entrapped on/in it)
a negative susceptibility at high magnetic fields and at high temperatures is observed. For the thermoresponsive nanocubes, this further corroborates the presence of a polymer, the thermo-responsive shell, at the surface of nanocubes. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 
Cytotoxicty assay
Besides tuning the phase transition temperature for feasible applications at body temperature, for any material to be applicable as a drug delivery vehicle, it is imperative that the material is non-cytotoxic.
We studied the effect of our polymer coated (PNIPAAM-co-PEGA) nanocubes on Kb cells by conducting cell viability and cell uptake studies. Cell viability studies showed no difference in % viability between Kb cells incubated for 16 hours with polymer coated nanocubes at high concentration (1 g/L of iron) and Kb cells treated only with the corresponding amount of PBS, used as control; in a parallel experiment under the same conditions, cells that were rinsed from the excess of IONP and kept for additional 32 hours in incubation, also showed very high viability(in this case the total exposure time of cells to the cubicIONPs is of 48 h), indicating the nanohybrids were not cytotoxic ( Figure 6A ). On the other hand, as confirmed by measuring the iron amount by ICP, the uptake of the thermo-responsive coated nanocubes is slightly higher than that of similar nanocubes coated by only PEG or enwrapped in an amphiphilic polymer and as previously found by us 22 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 14 concentration of nanoparticles administered, the stability of the IONPs in cell medium was not compromised, leading to very few aggregates that do not cause any toxic response (figure S11 in the ESI). 
Drug loading and release experiments
Cubic-IONPs (LCST of sample, 47 o C) were loaded with doxo at room temperature and in order to demonstrate the temperature dependence of doxo release, the drug release was assessed at 4 o C, 25 o C, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 collected by means of a magnet leaving in solution the excess of doxo which was measured and then discarded. The drug loading achieved was 44.75% with respect to the initial doxo amount, , as measured by difference between the initial doxo absorbance and the absorbance of the supernatants (which contains the doxo not loaded into the polymer shell) found in the 5 washing steps. This also means that 67.125 µg of doxo were associated per 0.1 mg of iron. The release of the drug from the dispersion of doxo loaded nanoparticles (200 ppm in Fe) was found to be only 8% at 37 o C over 24 hours and even less at 25 o C and 4 o C. However, more than 90% of the drug was released in less than 5 hours at 50 o C clearly suggesting that the release was heat triggered ( Figure 7A ). In these cases a water bath was used to increase the temperature and after thermal treatment the thermo-responsive-IONPs were collected to the magnet and the supernatant analyzed for the doxo quantification by absorption. We also extended our study to demonstrate the "on-demand" and remotely triggered drug release by conducting drug release under an external activation, the AMF. We therefore prepared another sample (LCST, 52 o C) of drug loaded cubic-IONPs as described above but on a larger scale (6 mg Fe diluted to 50 ppm) and the drug loading achieved in this case was 23% (2.2 mg of doxo). Doxo release was observed to take place ) whilst negligible release was observed for a similar sample not subjected to an AMF ( Figure 7B and SI, Figure S6 ) and kept at 25 o C.
About 25% of the loaded drug was released over 240 minutes (Table S1 )."
During the AMF exposure at this nanocube concentration, the temperature of the solution reached 80 o C in the first 15 minutes which is clearly above the LCST of 52 °C of the thermo-responsive sample employed. Remarkably, the temperature profile of the PNIPAAM-co-PEGA cubic-IONPs is comparable to that of the same batch of cubic-IONPs brought in water by a chatecol-PEG using a ligand exchange procedure developed by our group ( Figure 7C ). 22 It is worth mentioning that when we used the waterbath, we could achieve the release even at nanocube concentration as low as 0.2 g/L of iron. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 However, under AMF, the temperature of a 0.2 g/L of iron solution did not increase and remained constant at 25 °C and under those conditions no drug release was observed. This suggests that the polymer shrinking with consequent drug release is a collective property which involves inter-particle interaction rather than a single particle shrinking process. In other words, to activate the shrinking of the nanosystem, a macroscopical temperature increase rather than local heating effects plays a major role.
Implementation of the polymerization procedure on nanocubes with pH-responsive monomer units
As a further extension of this work, to demonstrate the versatility of our synthetic approach, we also 
Control polymerization experiments using superparamagnetic and spherical IONPs
To confirm that the complication in functionalization of the cubic-IONPs resulted from their strongly interacting character, we functionalized spherical superparamagnetic IONPs synthesized by following the protocol reported by Colvin and coworkers. 35 Due to their superparamagnetic behavior at room temperature, these spherical-IONPs have no tendency to aggregate. The oleic acid capped sphericalIONPs were easily exchanged with the CTCLRA (see materials and method section) and on the CTCLRA functionalized nanoparticles polymerization with NIPAAMor PNIPAAM-co-PEGA could be undertaken with no difference either in dioxane or in THF affording water or PBS buffer (pH 7.4) dispersible thermoresponsive spherical-IONPs. In this case, no precipitation or aggregation was observed over entire Figure 2G ). In addition, an increase in size after polymerization was observed by DLS and thermo-responsiveness of the nanohybrids was ascertained by turbidimetric analysis (SI, Figure S9 -S10). This direct comparison just confirms that cubic-IONPs, which are strongly interacting nanoparticles, are more challenging to functionalize with respect to superparamagnetic IONPs which do not interact at all with each other.
Conclusion
In summary, we have developed a facile procedure to functionalize strongly interacting magnetic nanoparticles via RAFT polymerization with stimuli-responsive polymers and generate smart nanomaterials that have potential application in the biomedical field. Using our procedure, we successfully functionalized iron oxide nanocubes with a thermo-responsive and also with a pHresponsive polymer to obtain responsive biocompatible nanohybrids. The exploitation of the thermoresponsive hybrids was demonstrated by loading and release of an anti-cancer drug (doxo) into the nanohybrids which could be release, on demand, under an AMF due to the heat generated by the nanocubes. Such materials may provide a synergistic therapeutic effect in cancer treatment via hyperthermia and chemotherapy with triggered drug release while not displaying the side effects of standard chemotherapy.
Experimental Section
Materials. N-isopropylacrylamide (NIPAAM) (Aldrich, 99%) and N-isopropylmethacrylamide
(NIPMAM) (Aldrich, 99%) were purified by re-crystallization from hexane three times and dried under vacuum at room temperature before use. Poly(ethylene glycol) methyl ether acrylate (average M n 480) (Aldrich) and 4-vinyl pyridine (Aldrich) were destabilized by passing the monomer through a short column packed with inhibitor remover (Aldrich). Azobis(isobutyronitrile) (AIBN) was purified by recrystallization from methanol twice and then it was left to dry under reduced pressure in a desiccator. 
1,4 Dioxane (Sigma Aldrich, 99%) and tetrahydrofuran (THF) were distilled and stored under nitrogen
Synthesis of succinimide RAFT agent (SUCRA).
Scheme 1: SUCRA.
To a 500 mL round bottom flask was added BTTPA (10.00 g, 42.00 mmol), N-hydroxysuccinimide (7. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   22 shaker and left to shake vigorously overnight. The nanoparticles were recovered by centrifugation at 3500 rpm for 10 minutes and the collected nanoparticles were re-dispersed in THF. Hexane was added to near the point of particle precipitation (the amount of hexane added was such that no particle or CTCLRA precipitation was observed but further addition of hexane, few mL, would result in particle precipitation). The solution was centrifuged to recover the nanoparticles and the supernatant solution was decanted. This process was repeated until the characteristic yellow color of the RAFT agent in the supernatant disappeared after which the nanoparticles were washed two more times. The functionalized nanoparticles were insoluble in hexane which is a good solvent for the starting nanoparticles thus indicating the change in the coating at their surface. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 23 water bath at 60 o C for 3 h. The reaction was stopped by placing the vial in an ice bath and opening it to the atmosphere. A sample for analysis by SEC was obtained by taking an aliquot of the reaction mixture (ca. 100 mg in around 100 µL of the sample) which was diluted with THF and placed on a magnet to remove the nanoparticles prior to collection of the supernatant for analysis. The remainder of the reaction mixture was precipitated into cold diethyl ether and the collected precipitate was dissolved in a small amount of THF and reprecipitated in cold diethyl ether. This process was repeated one more time and the precipitate was then dissolved in THF/diethyl ether (1:2 in volume) and centrifuged at 5000 rpm for 10 minutes. The supernatant was decanted into cold hexane were precipitation of free polymer could be observed. The precipitated nanoparticles were resuspended in THF/diethyl ether (1:2) and centrifuged again at 5000 rpm for 10 minutes and this approach was repeated 3 times with the supernatant being poured into cold hexane. The supernatant from the last wash was concentrated on the rotary evaporator and analysed by SEC to confirm the absence of free polymer. In this case (no continuous sonication), the cubic-IONPs precipitated during the early stages of polymerization (ca. 10 mins).
Functionalization of cubic IONPs with thermo-responsive polymers (NIPAAM) in low viscosity
solvents under continuous sonication. The procedure followed is similar to that detailed above (when no sonication was employed) with the only difference being that instead of conducting the reaction in a thermostated water bath, the reaction vessel was placed in a sonication bath with sonication set at full power (30 W) and the temperature set at 60 o C for the entire duration of the polymerization. Worthily, in this case (under continuous sonication), the cubic-IONPs did not precipitate as observed in the previous case when no sonication was employed during the polymerization. However, though the temperature was set at 60 o C, it fluctuated significantly (60-85 o C) during the polymerization and it was very difficult to keep it within a small range of fluctuation (±2 o C) leading to poor reproducibility of results.
Functionalization of iron oxide nanocubes with CTCLRA after initially dispersing the IONPs in viscous solvent (Method 2).
A CHCl 3 solution of decanoic acid capped iron oxide nanocubes (5 mL, 0.14 µM, [Fe] 2.0 mg/mL, 18±2 nm edge length (TEM)) was added to a glass vial containing diethylene glycol (20 mL) which was sealed with a suba seal and degassed with nitrogen to evaporate off most of the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 and centrifuged at 4000 rpm for 10 minutes to recover the nanoparticles. The collected nanoparticles were redispersed in THF (20 mL) before hexane was added to near the point of particle precipitation (the amount of hexane added was such that no particle or RAFT agent precipitation was observed but further addition of hexane (few mL) would result in particle precipitation). The solution was centrifuged at 4000 rpm for 10 minutes to recover the nanoparticles and the supernatant solution was decanted.
This process was repeated with THF/hexane until the characteristic yellow color of the RAFT agent in the supernatant disappeared after which the nanoparticles were washed three more times. The 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 25 minute. The vial was sealed with a rubber septum, degassed with nitrogen gas for 30 minutes, and AIBN was then added from a stock solution in dioxane (25 µL, 3.28 µmol) via a microliter syringe. Degassing was continued for a further 10 minutes and the reaction contents were vortexed for a few seconds and the vial was placed in a thermostated water bath at 60 o C for 2 h. The reaction was stopped by placing the vial in an ice bath and opening it to the atmosphere. A sample for analysis by SEC was obtained by taking an aliquot of the reaction mixture (ca. 100 mg) which was diluted with THF (5 mL) and placed on a magnet to remove the nanoparticles prior to collection of the supernatant for analysis. The reaction mixture was precipitated into cold diethyl ether and the collected precipitate was dissolved in a small amount of THF and reprecipitated in cold diethyl ether. This process was repeated one more time and the precipitate was then dissolved in THF/diethyl ether (1:2) and centrifuged at 3500 rpm for 10 minutes. If the supernatant was decanted into hexane precipitation of free polymer could be observed.
The precipitated nanoparticles were resuspended in THF/diethyl ether (1:2) and centrifuged at 3500 rpm for 10 minutes and this approach was repeated 3 times with the supernatant being poured into hexane. The supernatant from the last wash was concentrated on the rotary evaporator dryness and analyzed by SEC to detect the presence of free polymer. If free polymer was detected, the nanoparticles were washed one more time and the supernatant analysed again by SEC. After the last wash, the nanoparticles were dispersed in 5 mL of THF and 1 mL of this solution was transferred to a glass vial which was placed on a magnet to precipitate the particles and the supernatant was filtered, concentrated to 0.3 mL by evaporation using a slow flow of nitrogen gas and subjected to analysis by SEC to verify the absence of free polymer in the sample (DRI/UV 306 nm). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 hours (1000 rpm) to load the drug within the polymer layer. The unloaded drug was removed by placing the solutions on a magnet whereupon the loaded nanoparticles sedimented and the free drug remained in solution and was drawn off using a micropipette. Fresh PBS buffer was then added to the vial with the nanoparticles in order to re-suspend them and more unloaded drug was then removed as previously described. The process was repeated (usually three to four times) until no absorption signal due to doxo in the supernatant was observed via UV spectroscopy (λ max 485 nm). For the sample used to demonstrate drug release under AMF, the amount of doxo loaded for 6 mg of iron was 2,2 mg which corresponds to 23% of doxo loading.
Drug release:
(i) Drug release in thermostated water bath. A colloidal solution of the drug loaded hybrid nanoparticles (2 mL, 200 ppm Fe) was placed in a thermostated water bath at a desired temperature (main text, figure 3A ) and at desired intervals, the samples were placed on a magnet for 5 minutes to attract the hybrid nanoparticles and the supernatant was analyzed by UV spectroscopy to determine the amount released using the Beer-Lambert-Law. After each absorption measurement, the supernatant was transferred back into the original vial and the nanoparticles were completely re-dissolved and then incubated again in the water bath. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 27 instrument and placed on the magnet for 5 minutes to collect the nanoparticles at the bottom of the vessel. The record of the UV-VIS absorption spectra on the supernatant allows for the measurement of the amount of drug released. After analysis of the supernatant, it was returned back into the vial containing the thermo-responsive coated nanoparticles and completely re-mixed before another cycle of AMF was applied for the desired period. At the next time point, the separation was reiterated and the amount released was again measuredby UV-vis spectroscopy. An aliquot of the doxo loaded sample was kept at room temperature and treated in the same way (but not subjected to an AMF) for comparison.
No unspecific release was measured on this sample (see SI).
Functionalization of superparamagnetic spherical nanoparticles (spherical-IONPs) with catechol
bearing RAFT agent (CTCLRA).
Scheme 5: Spherical-IONPs functionalized CTCLRA.
To a toluene solution of oleic acid capped spherical IONPs (4 mL, 0.6 µM, [Fe] 1.8 mg/mL, 14 nm diameter(TEM)) was added a THF solution of CTCLRA agent (24 mmol in 45 mL THF) and then a triethylamine (3 mL in 10 mL THF) was added. The resulting colloidal solution was left on a shaker overnight after which the nanoparticles were recovered by centrifugation at 4000 rpm for 10 minutes.
The collected nanoparticles were redispersed in THF and nanoparticles were washed by the excess of CTCLRA by centrifugation and re-dispersion: before centrifugation hexane was added to the vicinity of particle precipitation (the amount of hexane added was such that no particle precipitation was observed but further addition of hexane (few mL) would result in precipitation). The solution was centrifuged at 4000 rpm for 10 minutes to recover the nanoparticles and the supernatant solution was decanted. This 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 NPs). The solution was vortexed for a few seconds and the vial was sealed with a rubber septum followed by degassing with nitrogen gas for 30 mins. AIBN (25 µL, 3.28 µmol) was then added from a stock solution in dioxane via a microliter syringe and degassing was continued for a further 10 minutes.
The reaction contents were mixed for a few seconds and the vial was placed in a thermo-stated water bath at 60 o C for 3 h. The reaction was stopped by placing the vial in an ice bath and opening it to the atmosphere. A sample for analysis by SEC was obtained by taking an aliquot of the reaction mixture (ca.
100 mg in around 100 µL of the sample) which was diluted with THF and placed on a magnet to remove the nanoparticles prior to collection of the supernatant for analysis. The reaction mixture was precipitated into cold diethyl ether and the collected precipitate was dissolved in a small amount of THF and reprecipitated in cold diethyl ether. This process was repeated one more time and the precipitate was then dissolved in THF/diethyl ether (1:2 in volume) and centrifuged at 5000 rpm for 10 minutes. The supernatant was decanted into cold hexane were precipitation of free polymer could be observed. The precipitated nanoparticles were resuspended in THF/diethyl ether (1:2) and centrifuged again at 5000 rpm for 10 minutes and this approach was repeated 3 times with the supernatant being poured into cold hexane. The supernatant from the last wash was concentrated on the rotary evaporator and analyzed by SEC to confirm the absence of free polymer. 
Size exclusion chromatography (SEC):
SEC was used to determine the molecular weight of the polymers. SEC analyses were carried out at 60oC using an Agilent SEC system equipped with a guard column and two Agilent PolarGel M columns (molecular weight range of 500-2 000 000 g/mol) attached to a differential refractive index (DRI) detector. The flow rate of the system was set at 1 mL/min and the eluent was DMF with 0.3% (w/v) LiBr. The SEC system was calibrated using Agilent narrow molecular weight distribution polystyrene standards. 
Dynamic Light scattering (DLS):
Transmission electron microscopy (TEM):
Conventional TEM images were obtained using JEOL JEM 1011 electron microscope, working with an acceleration voltage of 100 kV and equipped with a W thermionic electron source and a 11Mp Orius CCD Camera (Gatan company, USA). Samples were prepared by placing a drop of sample onto a carbon coated copper grid which was then left to dry before imaging. Frozen hydrated samples were prepared by applying a 3 μl aliquot to a previously glowdischarged 200-mesh Quantifoil holey carbon grid (Ted Pella, USA). Before plunging the grid into liquid ethane, the grid was blotted for 1.5 s in a chamber at 4°C and 90% humidity using a FEI Vitrobot Mark IV (FEI company, the Netherlands). The particles were imaged, in both cryo-TEM and cryo-STEM mode, using a Jeol JEM 2200FS (Jeol, Japan) and a Tecnai G2 F20 microscopes (FEI company, the Netherlands),
respectively. Both the microscopes were equipped with a Schottky Field Emission electron source, a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 30 US1000 2kx2k Gatan CCD camera and operated at an acceleration voltage of 200 kV. The cryo-TEM imaging was carried out under low dose condition in order to limit water sublimation from the vitrified sample and its recrystallization on the specimen surface.
Fourier transform infra-red (FT-IR):
FT-IR spectra were recorded using a with a Bruker vertex 70v Fourier transform infrared spectrometer. Samples were prepared by placing a drop of sample onto a silicon wafer and left to dry in a desiccator at room temperature overnight before analysis.
Turbidimetric analysis:
Turbidimetric analyses were done using a Varian Cary 5000 UV-vis spectrophotometer equipped with Peltier elements for temperature control. Measurements were done on solutions of ca. 50 ppm (Fe) and before each measurement, the sample was left to equilibrate at the desired temperature for 3 minutes.
pH measurements:
Measurements were done using a calibrated Crison Basic 20 pH meter.
TGA analysis:
The weight loss of the functionalised nanoparticles was determined by using a TA Instruments Hi-Res TGA 2950 thermogravimetric analyzer under a nitrogen atmosphere (60 cm 3 /min).
The samples (2-3 mg) of the thermo-responsive coated nanocubes were heated from room temperature to 50 °C and isothermal for 15 mins then to 700 °C with the heating rate set at 5 °C/min.
Elemental analysis: Elemental analysis was carried out via Inductively Coupled Plasma (ICP)
Atomic Emission Spectroscopy on a ThermoFisher CAP 6000 series. The samples were prepared by digesting 25 µL of sample in 2 mL of aqua regia overnight followed by dilution with milliQ water to 25 mL. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 4.26 Drug release under an alternating magnetic field (AMF): The hyperthermia experiment was conducted using a NanoscaleBiomagnetics instrument (DM100 series) equipped with a temperaturemeasuring probe. The AMF was set at 220 kHz, 20kAm 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Graphic 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
Magnetic characterization:
